# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T23:45:20.657007
**Route:** OpenRouter + LaTeX
**Tokens:** 21604 in / 1931 out
**Response SHA256:** 5898208a70186b8b

---

I reviewed the draft checking only for FATAL errors per your instructions (data-design alignment, regression sanity, completeness, internal consistency). I inspected every table and all places where treatment timing, sample period, and regression outputs are reported.

Findings — no fatal errors identified

- Data-design alignment
  - Treatment timing vs. data coverage: Consistent. The paper states the analysis uses CPS ASEC surveys from March 2015–March 2024, corresponding to income years 2014–2023; treatment effective dates in Table A.2 are coded to first affected income years (e.g., Colorado Jan 1, 2021 → income year 2021; New York Sept 2023 → income year 2024). The key restriction (income years ≤ 2023) means New York and Hawaii (first income year 2024) correctly have no post-treatment observations and are explicitly reported as receiving zero weight. The manuscript consistently reports 8 ever-treated states, 6 with post-treatment data, and the aggregation/estimation descriptions reflect that. I found no instance where the paper claims to estimate effects using post-treatment data that do not exist in the sample.
  - Post-treatment observations: For each cohort the number of post-treatment years is reported (e.g., Colorado 3, CT/NV 2, CA/WA/RI 1); the paper states that 2024 cohort has zero post-treatment years — consistent with the stated data window.
  - Treatment definition consistency: The treatment timing table (Appendix A.2 / Table \ref{tab:timing}) matches the coding rules described in the Data and Treatment Timing sensitivity sections. I saw no mismatch between the timing table and the treatment variable descriptions used in the regressions.

- Regression sanity
  - Standard errors and coefficients: I scanned all reported regression tables and robustness tables. No implausible numbers (extremely large SEs or coefficients) appear. Examples checked:
    - Table \ref{tab:main}: coefficients and SEs are modest in magnitude; R² values are within [0,1]; N is reported.
    - Event study table (Table \ref{tab:event_study}): coefficients and SEs are sensible (no NA/Inf/negative SE).
    - Robustness and bootstrap tables: SEs and CIs are numerically plausible; bootstrap p and CI reported.
  - R² values: all within valid range (e.g., 0.966, 0.051, 0.293, 0.377).
  - No "NA", "NaN", "Inf", negative standard errors, or obviously mis-scaled estimates (e.g., SE > 1000, or SE > 100× coefficient) were present.

- Completeness
  - No placeholders like "TBD", "TODO", "XXX", or "NA" in tables or notes.
  - Regression tables include observation counts (N), and standard errors are reported.
  - All referenced tables and figures appear present in the LaTeX source (main tables, robustness tables, event study, maps, appendices).
  - Methods described are accompanied by results (e.g., C-S estimator, Sun-Abraham, bootstrap), and robustness checks referenced have corresponding tables/figures.

- Internal consistency
  - Numbers cited in the text match table values (e.g., C-S ATT = -0.0105 (SE 0.0055) appears in abstract, body, and Table \ref{tab:robustness}).
  - Counts of ever-treated (8) and with post-treatment data (6) are consistently reported across the paper and appendix.
  - Treatment timing coding is applied consistently (conservative coding for partial-year laws, sensitivity check with aggressive coding described and reported).
  - Column headers and specification descriptions correspond to the contents of the columns.

Conclusion

I did not find any fatal errors in the four critical categories you specified. All treatment timing, sample-period, and cohort descriptions align with the data window; all reported regression outputs are numerically plausible and complete; required elements (N, SEs, CIs, robustness checks) are present; and the paper is internally consistent.

ADVISOR VERDICT: PASS